4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-23-036087
SVP of Business Development bought 10,000 shares at $2.16 ($21,574)
- SVP of Business Development acquired 5,356 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flowers Lee SVP of Business Development | 2023-06-08 | Option exercise | +5,356 | $0.14 | $750 | 101,308 | D: show line 1 in the form |
| Flowers Lee SVP of Business Development | 2023-06-08 | Purchase | +10,000 | $2.16 | $21,574 | 111,308 | D: show line 2 in the form |
| Open-market purchases · 10,000 sh · avg $2.16 · $21,574 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flowers Lee SVP of Business Development | 2023-06-08 | Option exercise · Stock Option (Right to Buy) | −5,356 | 7,501 | D: show line 3 in the form |
Loading xslF345X04/doc4.xml…